Scrip
Gilead's cystic fibrosis drug aztreonam gets FDA panel nod
11 December 2009
Sue Sutter
Please Login to read the full article.
11 December 2009
Sue Sutter
In a 15 to two vote, the US FDA's anti-infective drugs advisory panel said Gilead Sciences provided substantial evidence of the safety and efficacy of its investigational cystic fibrosis treatment Cayston (aztreonam lyophilised for inhalation solution).
The committee also voted...
Please Login to read the full article.
RELATED CONTENT
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
